|Reflection of an open-ended coaxial line and application to nondestructive measurement of materials|
JR Mosig, JCE Besson, M Gex-Fabry, FE Gardiol
IEEE Transactions on instrumentation and Measurement, 46-51, 1981
|Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: replication and extension in the Swiss health care system|
G Bondolfi, F Jermann, M Van der Linden, M Gex-Fabry, L Bizzini, ...
Journal of affective disorders 122 (3), 224-231, 2010
|Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors|
GB Ehret, C Voide, M Gex-Fabry, J Chabert, D Shah, B Broers, V Piguet, ...
Archives of internal medicine 166 (12), 1280-1287, 2006
|Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease|
GA Lodygensky, K Rademaker, S Zimine, M Gex-Fabry, AF Lieftink, ...
Pediatrics 116 (1), 1-7, 2005
|Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol|
N Rouge, E Allémann, M Gex-Fabry, L Balant, ET Cole, P Buri, E Doelker
Pharmaceutica Acta Helvetiae 73 (2), 81-87, 1998
|Frontal theta event-related synchronization: comparison of directed attention and working memory load effects|
P Missonnier, MP Deiber, G Gold, P Millet, M Gex-Fabry Pun, ...
Journal of neural transmission 113, 1477-1486, 2006
|Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication|
M Gex-Fabry, AE Balant-Gorgia, LP Balant
Therapeutic drug monitoring 25 (1), 46-53, 2003
|Mental and physical health in Rwanda 14 years after the genocide|
N Munyandamutsa, P Mahoro Nkubamugisha, M Gex-Fabry, A Eytan
Social psychiatry and psychiatric epidemiology 47, 1753-1761, 2012
|Mindfulness-based cognitive therapy for bipolar disorder: A feasibility trial|
B Weber, F Jermann, M Gex-Fabry, A Nallet, G Bondolfi, JM Aubry
European Psychiatry 25 (6), 334-337, 2010
|CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response|
M Gex-Fabry, CB Eap, B Oneda, N Gervasoni, JM Aubry, G Bondolfi, ...
Therapeutic drug monitoring 30 (4), 474-482, 2008
|Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors|
AE Balant-Gorgia, M Gex-Fabry, C Genet, LP Balant
Therapeutic drug monitoring 21 (1), 105-115, 1999
|Clinical pharmacokinetics of clomipramine|
AE Balant-Gorgia, M Gex-Fabry, LP Balant
Clinical pharmacokinetics 20, 447-462, 1991
|Determinants of postconflict symptoms in Albanian Kosovars|
A Eytan, M Gex-Fabry, L Toscani, L Deroo, L Loutan, PA Bovier
The Journal of nervous and mental disease 192 (10), 664-671, 2004
|Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ)|
BW Rouget, N Gervasoni, V Dubuis, M Gex-Fabry, G Bondolfi, JM Aubry
Journal of affective disorders 88 (1), 103-108, 2005
|Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study|
F R. Girardin, M Gex-Fabry, P Berney, D Shah, JM Gaspoz, P Dayer
American Journal of Psychiatry 170 (12), 1468-1476, 2013
|Clomipramine metabolism model-based analysis of variability factors from drug monitoring data|
M Gex-Fabry, AE Balant-Gorgia, LP Balant, G Garrone
Clinical pharmacokinetics 19, 241-255, 1990
|Methylation of NR3C1 is related to maternal PTSD, parenting stress and maternal medial prefrontal cortical activity in response to child separation among mothers …|
DS Schechter, DA Moser, A Paoloni-Giacobino, L Stenz, M Gex-Fabry, ...
Frontiers in psychology 6, 690, 2015
|Self-and clinician-rated Montgomery–Åsberg depression rating scale: Evaluation in clinical practice|
G Bondolfi, F Jermann, BW Rouget, M Gex-Fabry, A McQuillan, ...
Journal of affective disorders 121 (3), 268-272, 2010
|Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone|
M Benmebarek, C Devaud, M Gex‐Fabry, K Powell Golay, C Brogli, ...
Clinical Pharmacology & Therapeutics 76 (1), 55-63, 2004
|A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage|
N Turck, L Vutskits, P Sanchez-Pena, X Robin, A Hainard, M Gex-Fabry, ...
Intensive care medicine 36, 107-115, 2010